WHO guidelines for malaria vector control
The Guidelines for malaria vector control provide a “one-stop shop” for all countries and partners working to implement effective malaria vector control measures. They cover the 2 core malaria vector control interventions – ITNs and IRS – as well as supplementary interventions, namely chemical and biological larvicides, and personal protection measures, such as the use of topical repellents. Read more
Reminder: Project Manager Malaria at ISGlobal
ISGlobal is looking for an experienced Project Manager for the Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) project. Deadline for applications is 15 April 2019. Read more
Reminder: Clinical Trial Manager Malaria at ISGlobal
ISGlobal is looking for an experienced Clinical Trial Manager for the the Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) project. Read more
Global Malaria News
Mass drug administration against malaria seen effective
SciDev.Net, 4 March 2019
Medical researchers say that mass administration of combination drugs can stop the transmission of malaria caused by the Plasmodium falciparum parasite and reduce its prevalence in South-East Asian countries, where resistance of the disease to artemisinin, the standard drug, has hampered elimination efforts. Read more
A quick path to antimalarial resistance
ScienceDaily, 4 March 2019
Resistance to antimalarial drugs is thought to result mainly from changes in the parasite's genome. However, P. falciparum can also develop resistance to some antimalarial compounds by epigenetic changes, according to a new study. This is of concern because resistance acquired at the epigenetic level can arise quickly, even during the course of a single infection. Read more
Earlier emergence of malaria in Africa
ScienceDaily, 28 February 2019
Malaria is one of the leading causes of death by an infectious agent, the Plasmodium falciparum parasite. In research on malaria, the genetic mutation that causes sickle cell anemia (also known as drepanocytosis), a chronic disease that is often fatal in children under five, caught the attention of the scientific community very early on because it also provides protection against malaria. Read more
Enjoy this week's MalariaWorld - the MW team
Malaria is on the rise in more than 13 countries. And that is very scary!
This year's report shows that after an unprecedented period of success in global malaria control, progress has stalled. Data from 2015–2017 highlight that no significant progress in reducing global malaria cases was made in this period. There were an estimated 219 million cases and 435 000 related deaths in 2017.
The World malaria report 2018 draws on data from 91 countries and areas with ongoing malaria transmission. The information is supplemented by data from national household surveys and databases held by other organizations.
The most promising or the most frightening experiment in the fight against malaria: should or shouldn’t we use genetically modified mosquitoes to combat malaria?
I visited the largest malaria conference on the African continent. More than 2.000 malaria professionals gathered in Dakar for the 7th Multilateral Initiative on Malaria Conference. Every day started with a plenary session presented by 2 keynote speakers: 12 keynote addresses by 12 renowned scientists. But... only 2 were African.
Stephen L. Hoffman
Keynote speaker MIM 2018
8 March 2018, Carl Zimmer (New York Times)
The genetic mutation arose 7,300 years ago in just one person in West Africa, scientists reported on Thursday. Its advantage: a shield against rampant malaria.
Thousands of years ago, a special child was born in the Sahara. At the time, this was not a desert; it was a green belt of savannas, woodlands, lakes and rivers. Bands of hunter-gatherers thrived there, catching fish and spearing hippos.